ArticleClinical and experimental nephrology2025
Effectiveness and safety of ravulizumab for Japanese patients with atypical hemolytic uremic syndrome switched from eculizumab: an analysis of a post-marketing surveillance.
Shuichi Ito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.